Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome
Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome. A Randomized, Double-Blind, Placebo-Controlled Trial
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Terminated
Poor recruitment
Other terminated trials from London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other Polycystic Ovary Syndrome trials with similar outcome
Listed as NCT00884819, this NA trial focuses on Polycystic Ovary Syndrome and remains terminated or withdrawn. Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Apr 2025 — Present [monthly]
Terminated NA
-
Jan 2025 — Apr 2025 [monthly]
Terminated NA
-
Sep 2024 — Jan 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Dec 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
For direct contact, visit the study record on ClinicalTrials.gov .